demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
anti-inflammatory therapies
clarithromycine Rashad ...
colchicine COL-COVID ...
non-steroidal anti-inflammatory drugs Guzman-Esquivel
Indomethacin Ravichandran

0 studies excluded by filtering options 1